Klotho gene therapy safety trial
This trial tests a new gene therapy that uses a harmless piece of DNA (called a plasmid) to help your body make more Klotho, a protein linked to healthy aging. The goal is to see if it's safe and whether it might slow aging or improve health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be open to changes in your appearance or body shape.
- Women who could become pregnant must agree to use birth control and take pregnancy tests.
- You cannot have a history of cancer, or any medical condition that could be made worse by the treatment.
- You must not have had any gene therapy in the past year.
- You must be able to give written permission (informed consent) to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage trial testing a new type of treatment called mRNA therapy that helps your body make missing proteins. Researchers are enrolling healthy volunteers to understand how safe and well-tolerated this approach is.
This trial tests a gene therapy that may help rebuild muscle and improve blood vessel growth in people ages 35 to 75. It's designed for those with stable health conditions and no history of cancer, heart disease, blood clots, or diabetes.
This trial tests a new way to rebuild your blood stem cells to possibly slow down aging. It is for healthy adults aged 45 to 65 without serious illnesses or recent cancer.
This trial tests a gene therapy for people with advanced Parkinson's disease (at least 10 years since diagnosis). It uses a special infusion to deliver treatment directly into the brain. The goal is to see if it can improve motor symptoms.
This trial tests a new gene therapy called YOLT-101 for people with familial hypercholesterolemia, a genetic condition that causes very high cholesterol. The treatment aims to lower cholesterol levels and reduce heart risks.
This study tests a new gene therapy (chemogenetics) to see if it is safe and how well it works for people with Parkinson's disease. The treatment involves a one-time infusion of a modified virus into the brain to help control movement symptoms.
Hear when a new Healthy Adults trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.